tiprankstipranks
Advertisement
Advertisement

PRAX Stock Latest News

Praxis Therapeutics: Strengthened Ulixacaltamide IP Underscores Franchise Durability; Buy Rating and $1,245 Price Target Reiterated
RatingsPraxis Therapeutics: Strengthened Ulixacaltamide IP Underscores Franchise Durability; Buy Rating and $1,245 Price Target Reiterated
6d ago
PRAX
Praxis Highlights FDA NDA Acceptances and Strengthened Cash Runway
PremiumCompany Announcements
Praxis Highlights FDA NDA Acceptances and Strengthened Cash Runway
19d ago
8K
PRAX
Praxis Precision assumed with a Buy at Truist
PremiumThe Fly
Praxis Precision assumed with a Buy at Truist
19d ago
PRAX
Praxis Precision Medicines Maps High-Stakes Launch Path
PremiumCompany Announcements
Praxis Precision Medicines Maps High-Stakes Launch Path
21d ago
PRAX
Xenon Pharmaceuticals price target raised to $69 from $68 at Wells Fargo
PremiumThe Fly
Xenon Pharmaceuticals price target raised to $69 from $68 at Wells Fargo
22d ago
PRAX
XENE
Praxis Precision price target lowered to $420 from $444 at Deutsche Bank
PremiumThe FlyPraxis Precision price target lowered to $420 from $444 at Deutsche Bank
24d ago
PRAX
Praxis Precision price target raised to $166 from $130 at Wedbush
Premium
The Fly
Praxis Precision price target raised to $166 from $130 at Wedbush
24d ago
PRAX
Praxis Therapeutics: Advancing Late-Stage Neurology Pipeline and De-Risked Ulixacaltamide NDA Support Unchanged $554 Buy Target
Premium
Ratings
Praxis Therapeutics: Advancing Late-Stage Neurology Pipeline and De-Risked Ulixacaltamide NDA Support Unchanged $554 Buy Target
25d ago
PRAX
Praxis Precision reports Q1 EPS ($3.20), consensus ($3.68)
PremiumThe Fly
Praxis Precision reports Q1 EPS ($3.20), consensus ($3.68)
25d ago
PRAX
Praxis Precision price target raised to $437 from $412 at Deutsche Bank
PremiumThe Fly
Praxis Precision price target raised to $437 from $412 at Deutsche Bank
2M ago
PRAX
Praxis Precision NDA for Ulixacaltamide in Essential Tremor
PremiumCompany Announcements
Praxis Precision NDA for Ulixacaltamide in Essential Tremor
2M ago
8K
PRAX
Praxis Precision announces FDA acceptance of ulixacaltamide NDA
PremiumThe Fly
Praxis Precision announces FDA acceptance of ulixacaltamide NDA
2M ago
PRAX
Praxis Precision Medicines: Advancing CNS Pipeline and Near-Term Data Catalysts Support Buy Rating Despite Cash Burn
PremiumRatingsPraxis Precision Medicines: Advancing CNS Pipeline and Near-Term Data Catalysts Support Buy Rating Despite Cash Burn
2M ago
PRAX
Praxis Precision initiated with a Strong Buy at Raymond James
Premium
The Fly
Praxis Precision initiated with a Strong Buy at Raymond James
2M ago
PRAX
Praxis Precision initiated with a Strong Buy at Raymond James
Premium
The Fly
Praxis Precision initiated with a Strong Buy at Raymond James
2M ago
PRAX
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts
2M ago
IVA
OVID
Praxis: EMBRAVE Data Validate Elsunersen and De‑Risk Pipeline, Supporting Buy Rating on Favorable Risk‑Reward
PremiumRatings
Praxis: EMBRAVE Data Validate Elsunersen and De‑Risk Pipeline, Supporting Buy Rating on Favorable Risk‑Reward
2M ago
PRAX
Praxis reports positive elsunersen trial in pediatric epilepsies
PremiumCompany Announcements
Praxis reports positive elsunersen trial in pediatric epilepsies
2M ago
8K
PRAX
Praxis Precision Medicines: Advancing Late-Stage Neurology Pipeline Underpins Outperform Rating and $53 Price Target
PremiumRatings
Praxis Precision Medicines: Advancing Late-Stage Neurology Pipeline Underpins Outperform Rating and $53 Price Target
2M ago
PRAX
Praxis Precision announces topline results from EMBRAVE Part A trial
PremiumThe FlyPraxis Precision announces topline results from EMBRAVE Part A trial
2M ago
PRAX
Praxis Precision announces FDA acceptance for priority review of relutrigine NDA
Premium
The Fly
Praxis Precision announces FDA acceptance for priority review of relutrigine NDA
2M ago
PRAX
Praxis Precision management to meet with Piper Sandl;er
Premium
The Fly
Praxis Precision management to meet with Piper Sandl;er
2M ago
PRAX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >